Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Easing Psychosocial Burden for Informal Caregivers

Early Phase 1

Completed

Conditions: Glioblastoma

Interventions: Behavioral: Focus Group
Behavioral: Meaning-Centered Psychotherapy for Cancer Caregivers / MCP-C
Behavioral: Enhanced Usual Care / EUC

First Posted Date: 2018-03-05

Last Posted Date: 2024-04-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 64

Registration Number: NCT03454295

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Commack (Consent only), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent only), Harrison, New York, United States

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

Recruiting

Conditions: Osteosarcoma
Chondrosarcoma
Bone Sarcoma
Ewing's Sarcoma
Bone Neoplasm
Osseous Sarcoma

Interventions: Behavioral: Toronto Extremity Salvage Score
Behavioral: Musculoskeletal Tumor Society Score
Behavioral: Timed Get Up and Go Test
Diagnostic Test: Orthogonal Radiographs
Diagnostic Test: Weight Bearing for lower extremities only
Diagnostic Test: Range of Motion

First Posted Date: 2018-02-22

Last Posted Date: 2025-05-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 180

Registration Number: NCT03442465

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Consent and Followup), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent and Followup), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: Apalutamide
Drug: Abiraterone Acetate
Radiation: Stereotactic Body Radiation Therapy
Procedure: Extended Pelvic lymphadenectomy
Drug: Prednisone
Procedure: Radical Prostatectomy
Drug: GnRH agonist/antagonist

First Posted Date: 2018-02-19

Last Posted Date: 2024-11-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 102

Registration Number: NCT03436654

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Northwestern University, Evanston, Illinois, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

and more 8 locations

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Phase 2

Completed

Conditions: Acute Myeloid Leukemia
Myelodysplastic-Myeloproliferative Diseases
Leukemia
Acute Lymphoblastic Leukemia
Hodgkin Lymphoma
Acute Leukemia
Myelodysplastic Syndromes
Myeloproliferative Disorder
Non Hodgkin Lymphoma

Interventions: Radiation: Total Body Irradiation
Drug: Cyclosporine
Drug: Mycophenolate Mofetil
Drug: Tocilizumab
Drug: Filgrastim

First Posted Date: 2018-02-15

Last Posted Date: 2025-04-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 46

Registration Number: NCT03434730

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection

Phase 3

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Propofol+ Rocuronium+ Fentanyl + Inhalational
Drug: Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml
Procedure: Open Pancreaticoduodenectomy

First Posted Date: 2018-02-15

Last Posted Date: 2024-07-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 133

Registration Number: NCT03434678

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Commack (Consent only), Commack, New York, United States

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

Active, not recruiting

Conditions: Colon Cancer
Liver Tumors

Interventions: Other: blood draws
Procedure: colectomy or hepatectomy
Diagnostic Test: Fibroscan test

First Posted Date: 2018-02-14

Last Posted Date: 2025-04-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 51

Registration Number: NCT03432806

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 1 locations

Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract

Phase 2

Completed

Conditions: Non-Transitional Cell Carcinoma of the Urothelial Tract
Small Cell of the Bladder
Squamous Cell Carcinoma of the Bladder
Metastatic Bladder Cancer
Adenocarcinoma of the Bladder

Interventions: Drug: durvalumab and tremelimumab

First Posted Date: 2018-02-13

Last Posted Date: 2021-12-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 15

Registration Number: NCT03430895

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memoral Sloan Kettering Westchester, Harrison, New York, United States

and more 1 locations

Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography

Completed

Conditions: Anesthesia

Interventions: Other: Blind Gastric Tube Placement

First Posted Date: 2018-02-13

Last Posted Date: 2019-06-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 166

Registration Number: NCT03430908

Locations: 🇺🇸
Memorial Sloan - Kettering Cancer Center, New York, New York, United States

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

Active, not recruiting

Conditions: Breast Cancer

Interventions: Behavioral: Harvard Health Professionals survey
Procedure: Research Tissue sampling
Other: Blood draw
Other: CPET Procedures
Other: stool sample

First Posted Date: 2018-02-07

Last Posted Date: 2024-08-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT03424915

Locations: 🇺🇸
Memorial Sloan Kettering Commack (Consent and Follow-up), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent and Follow-up), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (Consent and Follow-up), New York, New York, United States

and more 4 locations

Treating Patients With Melanoma and ALK Alterations With Ensartinib

Phase 2

Active, not recruiting

Conditions: Melanoma

Interventions: Drug: Ensartinib
Diagnostic Test: ALKATI by Customized Nanostring Assay

First Posted Date: 2018-02-05

Last Posted Date: 2025-02-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT03420508

Locations: 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy